Chlorine in PDB 6z20: Structure of the EC2 Domain of CD9 in Complex with Nanobody 4C8

The structure of Structure of the EC2 Domain of CD9 in Complex with Nanobody 4C8, PDB code: 6z20 was solved by W.Oosterheert, J.Manshande, N.M.Pearce, M.Lutz, P.Gros, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	60.71 / 2.68
Space group	I 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	75.645, 121.415, 129.249, 90.00, 90.00, 90.00
R / Rfree (%)	20.6 / 24.8

The binding sites of Chlorine atom in the Structure of the EC2 Domain of CD9 in Complex with Nanobody 4C8 (pdb code 6z20). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure of the EC2 Domain of CD9 in Complex with Nanobody 4C8, PDB code: 6z20:

Chlorine binding site 1 out of 1 in the Structure of the EC2 Domain of CD9 in Complex with Nanobody 4C8


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Structure of the EC2 Domain of CD9 in Complex with Nanobody 4C8 within 5.0Å range: probe atom residue distance (Å) B Occ D:Cl201 b:57.8 occ:1.00 H D:SER54 2.4 85.8 1.0 H D:LEU57 2.6 78.7 1.0 HA3 D:GLY52 2.8 72.2 1.0 H D:ASP56 2.9 83.3 1.0 HG D:LEU57 3.0 72.8 1.0 H D:TRP53 3.1 81.7 1.0 H D:GLY55 3.2 86.6 1.0 HB2 D:ASP56 3.2 96.0 1.0 HB2 D:SER54 3.2 84.9 1.0 N D:SER54 3.2 70.5 1.0 N D:TRP53 3.4 67.0 1.0 HE3 D:TRP53 3.4 67.9 1.0 N D:LEU57 3.4 64.6 1.0 HB2 D:LEU57 3.5 69.9 1.0 N D:ASP56 3.5 68.4 1.0 C D:GLY52 3.6 66.3 1.0 CA D:GLY52 3.6 59.2 1.0 HD11 D:LEU57 3.6 76.8 1.0 N D:GLY55 3.7 71.1 1.0 CG D:LEU57 3.8 59.6 1.0 CB D:SER54 3.9 69.7 1.0 CA D:SER54 3.9 71.0 1.0 CB D:LEU57 4.0 57.2 1.0 CB D:ASP56 4.0 79.0 1.0 CA D:ASP56 4.1 71.5 1.0 C D:SER54 4.1 71.5 1.0 C D:TRP53 4.1 71.2 1.0 HB2 D:TRP53 4.2 79.1 1.0 CD1 D:LEU57 4.2 63.0 1.0 H D:GLY52 4.2 67.9 1.0 CA D:TRP53 4.2 68.0 1.0 OG D:SER54 4.3 74.3 1.0 CE3 D:TRP53 4.3 55.5 1.0 C D:ASP56 4.3 69.7 1.0 HA2 D:GLY52 4.3 72.2 1.0 OD1 D:ASP56 4.3 90.3 1.0 CA D:LEU57 4.3 56.4 1.0 O D:GLY52 4.4 71.8 1.0 C D:GLY55 4.4 68.3 1.0 N D:GLY52 4.4 55.5 1.0 HD12 D:LEU57 4.5 76.8 1.0 CA D:GLY55 4.5 68.6 1.0 HG D:SER54 4.5 90.4 0.0 HG C:SER164 4.7 83.4 0.0 CG D:ASP56 4.7 87.6 1.0 HB3 D:ASP56 4.7 96.0 1.0 CB D:TRP53 4.7 64.8 1.0 HB3 D:SER54 4.7 84.9 1.0 HA2 D:GLY55 4.8 83.6 1.0 HA D:SER54 4.8 86.5 1.0 HZ3 D:TRP53 4.8 62.6 1.0 HB3 D:LEU57 4.9 69.9 1.0 O D:LEU57 4.9 56.8 1.0

W.Oosterheert, K.T.Xenaki, V.Neviani, W.Pos, S.Doulkeridou, J.Manshande, N.M.Pearce, L.M.Kroon-Batenburg, M.Lutz, P.M.Van Bergen En Henegouwen, P.Gros. Implications For Tetraspanin-Enriched Microdomain Assembly Based on Structures of CD9 with Ewi-F. Life Sci Alliance V. 3 2020.
ISSN: ESSN 2575-1077
PubMed: 32958604
DOI: 10.26508/LSA.202000883